RecruitingNCT06653660

Exposure to Organochlorine Pollutants and Impact on Development in the Peripubertal Age in Guadeloupe


Sponsor

Centre Hospitalier Universitaire de la Guadeloupe

Enrollment

650 participants

Start Date

Dec 19, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

In the context of environmental pollution of the French West Indies by chlordecone and questions about health consequences, monitoring at the peripubertal age of children born alive in the TIMOUN cohort is justified in several respects: - existence of an already established mother-child cohort whose live-born children will reach peripubertal ages during the period 2020-2022; - opportunity to verify hypotheses put forward on the basis of toxicological data acquired in laboratory animals and the hormonal characteristics of chlordecone (endocrine disruptor); - strong societal demand for such research to be carried out because of concerns about the sensitivity of children and adolescents to the effects of environmental xenobiotics, in particular on sexual development and the age of puberty; - recommendation of the Scientific Council Chlordecone Inserm - InVS; specific action of the National Plan Chlordecone IV.


Eligibility

Min Age: 16 YearsMax Age: 22 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Clinical examination for people with postnatal exposure and prenatal exposure. The study is currently recruiting participants at 1 location. People eligible for this study include aged 16 Years to 22 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERClinical examination

For the aim of the present study, we will follow-up children born alive in the TIMOUN cohort at peripubertal age. Questionnaires will be administered to parents on the child's health and lifestyle. Stature-weight anthropometric and cardio-dynamic measurements of the child will be obtained. Scores on three cognitive tests will be obtained. Furthermore, steroid hormones and chlordecone in the child's peripheral blood will be determined.


Locations(1)

CHU of Guadeloupe

Pointe-à-Pitre, Guadeloupe, Guadeloupe

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06653660